Back to BlackRock, Inc. BlackRock, Inc.

ALXOALXO
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ALX ONCOLOGY HLDGS INC

BlackRock, Inc. holds 7.4M shares of ALXO (ALX ONCOLOGY HLDGS INC), worth $15.3M as of 2026-Q2. The position was increased (+1552.4% shares). ALXO represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$15.3M

Current Shares

7.4M

Total Value Change

+$11.3M

Total Shares Change

+5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.4M
+1552.4%
$15.3M0.0%$2.07
45
2026-Q1
Decreased
447,799
-0.6%
$897,8360.0%$2.07
0
2025-Q4
Increased
450,430
+0.6%
$508,9860.0%$1.19
16
2025-Q3
Decreased
447,692
-37.5%
$819,2770.0%$1.75
0
2025-Q2
Decreased
716,297
-69.0%
$297,3350.0%$0.41
0
2025-Q1
Decreased
2.3M
-3.0%
$1.4M0.0%$0.65
0
2024-Q4
New
2.4M
-
$4M0.0%$1.66
37

Other major holders of ALXO: Janus Henderson Group Ltd., Invesco Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used